Selected article for: "potential target and small molecule"

Author: Lee, Na-Ra; Kwon, Hyun-Mi; Park, Kkothanahreum; Oh, Sangtaek; Jeong, Yong-Joo; Kim, Dong-Eun
Title: Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13
  • Document date: 2010_7_29
  • ID: 1k99yv4i_2
    Snippet: Since the viral helicase has been identified as a potential target for therapy in other viruses due to its indispensability in viral genome replication (10) (11) (12) , SCV NTPase/ Helicase (nsP13), which was recently purified and characterized, was suggested as an attractive target for the development of anti-SCV agents (7) . Thus, a lot of efforts have been made to identify and test small molecule inhibitors of the SCV helicase as drug candidat.....
    Document: Since the viral helicase has been identified as a potential target for therapy in other viruses due to its indispensability in viral genome replication (10) (11) (12) , SCV NTPase/ Helicase (nsP13), which was recently purified and characterized, was suggested as an attractive target for the development of anti-SCV agents (7) . Thus, a lot of efforts have been made to identify and test small molecule inhibitors of the SCV helicase as drug candidates (13) (14) (15) (16) . RNA and DNA aptamers against SCV helicase were also reported to have an inhibitory effect against nucleic acids unwinding (17, 18) . Although the tertiary structure of the SCV NTPase/Helicase has not been experimentally verified, the structure prediction of the protein was recently reported (19, 20) . SCV nsP13 has been shown to contain two separate domains, i.e. the helicase domain (Hel) and a metal-binding domain (MBD), which consists of several conserved Cys/His residues at the N-terminal (6, 19) . The SCV helicase Hel domain has been categorized into the Superfamily I helicase based on the conserved sequence motifs as shown in the Escherichia coli Rep helicase (21) .

    Search related documents:
    Co phrase search for related documents
    • attractive target and viral genome replication: 1, 2
    • attractive target and viral helicase: 1, 2, 3
    • drug candidate and therapy potential target: 1
    • drug candidate and viral genome replication: 1
    • drug candidate and viral helicase: 1
    • Escherichia coli and therapy potential target: 1, 2
    • Escherichia coli and viral genome replication: 1, 2, 3, 4
    • Escherichia coli and viral helicase: 1
    • Escherichia coli and virus therapy potential target: 1
    • genome replication and therapy potential target: 1
    • genome replication and viral genome replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • genome replication and viral helicase: 1, 2, 3, 4, 5, 6, 7
    • helicase domain and viral genome replication: 1
    • helicase domain and viral helicase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • inhibitory effect and therapy potential target: 1
    • inhibitory effect and viral genome replication: 1, 2, 3, 4
    • inhibitory effect and viral helicase: 1
    • molecule inhibitor and viral helicase: 1
    • nucleic acid and viral genome replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12